From Cancer Drugs to Kilowatts: A NASDAQ Company's Bet on the AI Power Crunch

Stock Information for Stem Inc. Class A

Loading

Please wait while we load your information from QuoteMedia.

More Recent News About Stem Inc. Class A

A Nasdaq Company Just Reinvented Itself as a Power Company - and Bet It All on the AI Energy Crunch
The AI Boom's Real Bottleneck Is Power - and One Nasdaq Company Is Reinventing Itself to Solve It
LIXTE Biotechnology Provides Update on NOMAD Acquisition; Transaction Expected to Close On or About July 1, 2026
The New Bottleneck Isn't Computing Power - It's Just Power
LIXTE Biotechnology to Acquire NOMAD Transportable Power Systems, the Market Leader in Mobile, Utility-Grade Battery Energy Storage Systems (BESS)
LIXTE Biotechnology Announces $16,566,027 Registered Direct Offering Priced at the Market Under Nasdaq Rules, Strengthening Balance Sheet for Next Phase of Strategic Growth
LIXTE Biotechnology Announces Strategic Transformation into AI Energy Infrastructure Equipment & Services; Stuart D. Porter, Founder of Denham Capital, to Join Board of Directors
LIXTE Biotechnology Files First Quarter 2026 Quarterly Report on Form 10-Q; Provides Operational Progress Update

Market data content copyright © QuoteMedia. Data delayed at least 15 minutes unless otherwise indicated (view Delay Times for all exchanges). Filings and Fundamentals by Morningstar. Insiders by Morningstar (USA) and SEDI (CDN). Analyst ratings by Zacks. Terms of Use.